Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMC 1865333)

Published in Am J Pathol on December 01, 1996

Authors

P Bugert1, G Kovacs

Author Affiliations

1: Department of Urology, Ruprecht Karls University, Heidelberg, Germany.

Articles citing this

Renal cell carcinoma. Cancer Biomark (2010) 1.56

High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer (2009) 1.55

Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol (1998) 1.24

CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A. Am J Pathol (2001) 1.12

Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer (2010) 1.08

Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability. J Mol Diagn (2002) 1.04

A renal cell carcinoma with components of both chromophobe and papillary carcinoma. Virchows Arch (2006) 0.99

Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours. Int J Biol Sci (2009) 0.89

Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma. J Med Genet (2001) 0.85

Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases. Virchows Arch (2013) 0.84

Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites. Am J Pathol (1996) 0.83

Premalignant lesions of the kidney share the same genetics changes as conventional renal cell carcinoma. World J Urol (2003) 0.79

Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas. J Cancer Res Clin Oncol (1997) 0.79

Lack of interleukin 6 (IL-6) and transforming growth factor alpha (TGF-alpha) expression in chromophobe renal cell carcinomas. Br J Cancer (1998) 0.79

Differential expression of a new isoform of DLG2 in renal oncocytoma. BMC Cancer (2006) 0.79

Chromophobe renal cell carcinoma with microcystic and adenomatous arrangement and pigmentation--a diagnostic pitfall. Morphological, immunohistochemical, ultrastructural and molecular genetic report of 20 cases. Virchows Arch (2005) 0.78

Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway. Onco Targets Ther (2016) 0.76

Molecular diagnosis of metastasizing oligodendroglioma: a case report. J Mol Diagn (2004) 0.76

[Cystic renal neoplasms. New entities and molecular findings]. Pathologe (2010) 0.75

[Identification of VHL-associated changes in clear cell renal carcinoma: the application of combined genome and expression analyses]. Pathologe (2009) 0.75

Articles cited by this

A genetic model for colorectal tumorigenesis. Cell (1990) 44.37

Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet (1994) 10.14

Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature (1987) 3.46

Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract (1986) 2.19

Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol (1995) 1.63

Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol (1994) 1.62

Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58

Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res (1996) 1.52

Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res (1992) 1.52

Allelotype of human bladder cancer. Cancer Res (1994) 1.38

Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res (1992) 1.31

Molecular cytogenetics of renal cell tumors. Adv Cancer Res (1993) 1.29

Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res (1989) 1.28

Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer (1991) 1.26

Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res (1994) 1.21

Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res (1994) 1.19

Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc Natl Acad Sci U S A (1995) 1.12

Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res (1995) 1.10

Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res (1993) 1.08

Molecular differential pathology of renal cell tumours. Histopathology (1993) 1.08

Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. Oncogene (1993) 1.01

Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Natl Cancer Inst (1989) 0.98

Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res (1995) 0.98

Adult renal epithelial neoplasms. Am J Clin Pathol (1995) 0.96

Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc Natl Acad Sci U S A (1994) 0.89

Distal nephron renal tumors: microsatellite allelotype. Cancer Res (1996) 0.89

Diagnosis and prognosis of renal-cell tumors: a molecular approach. World J Urol (1995) 0.84

Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603. Cancer Res (1995) 0.80

Articles by these authors

(truncated to the top 100)

The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene (2007) 4.81

Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med (2001) 4.19

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09

Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene (2007) 2.68

Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet (1993) 2.64

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45

A region of right posterior superior temporal sulcus responds to observed intentional actions. Neuropsychologia (2004) 2.05

Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med (2001) 1.84

Combined use of clinical assessment and d-dimer to improve the management of patients presenting to the emergency department with suspected deep vein thrombosis (the EDITED Study). J Thromb Haemost (2003) 1.69

Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol (1994) 1.62

Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Hum Reprod (1999) 1.59

Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer (2005) 1.46

Focal therapy in prostate cancer-report from a consensus panel. J Endourol (2010) 1.43

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. Br J Cancer (2008) 1.37

Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer (1997) 1.19

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. Br J Cancer (2008) 1.13

Specific chromosome aberration in human renal cell carcinoma. Int J Cancer (1987) 1.13

Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer (1992) 1.10

Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours. Oncogene (1998) 1.08

The association between a prolonged stay in the emergency department and adverse events in older patients admitted to hospital: a retrospective cohort study. BMJ Qual Saf (2011) 1.08

Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance. Prostate Cancer Prostatic Dis (2008) 1.07

Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol Psychiatry (2008) 1.05

Synaptic disinhibition during maintenance of long-term potentiation in the CA1 hippocampal subfield. Proc Natl Acad Sci U S A (1994) 1.04

Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. J Pathol (1997) 1.03

Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping. Hum Pathol (2001) 1.01

Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J (1997) 1.00

Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas. J Pathol (1996) 0.99

High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology (1993) 0.98

Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest (1997) 0.98

Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. J Pathol (1992) 0.97

Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol (1999) 0.96

Lifeguard--a personal physiological monitor for extreme environments. Conf Proc IEEE Eng Med Biol Soc (2004) 0.96

Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent. FASEB J (1998) 0.95

Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour. J Pathol (1997) 0.95

Cannulation of the ascending aorta for perfusion during cardiopulmonary bypass. A new technique and analysis of results. J Cardiovasc Surg (Torino) (1968) 0.94

Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins. Aust N Z J Obstet Gynaecol (2000) 0.94

Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Genetics of familial renal carcinoma. Ann Intern Med (1993) 0.93

Telomeric association in two human renal tumors. Cancer Genet Cytogenet (1987) 0.92

Zinc transporters in prostate cancer. Mol Aspects Med (2013) 0.92

High density deletion mapping of bladder cancer localizes the putative tumor suppressor gene between loci D8S504 and D8S264 at chromosome 8p23.3. Lab Invest (2000) 0.91

Homogeneously staining regions on marker chromosomes in malignancy. Int J Cancer (1979) 0.91

Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas. J Pathol (1998) 0.90

Premature chromosome condensation: evidence for in vivo cell fusion in human malignant tumours. Int J Cancer (1985) 0.90

NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension. Br J Pharmacol (2014) 0.88

Clonal aberrations of chromosomes X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosomes Cancer (1992) 0.88

FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosomes Cancer (1997) 0.87

Trisomy 7 and 17 mark papillary renal cell tumours irrespectively of variation of the phenotype. J Clin Pathol (2009) 0.87

Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification. Mod Pathol (1999) 0.86

Three isodicentric Philadelphia chromosomes in acute phase of chronic myeloid leukemia: a case report. Cancer Genet Cytogenet (1986) 0.86

Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma. Anticancer Res (1989) 0.86

Cranial CT scans--emergency department utilization. J Emerg Med (1994) 0.85

Microsatellite analysis reveals deletion of a large region at chromosome 8p in conventional renal cell carcinoma. Int J Cancer (1999) 0.85

Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients. Eur Respir J (2011) 0.84

Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes. Histopathology (2004) 0.84

Alteration of mitochondrial DNA in human oncocytomas. Genes Chromosomes Cancer (1989) 0.84

Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives. Hum Reprod (2000) 0.84

Renal oncocytoma. A cytogenetic and morphologic study. Cancer (1987) 0.84

Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study. Mod Pathol (1993) 0.84

Diagnosis and prognosis of renal-cell tumors: a molecular approach. World J Urol (1995) 0.84

Abnormalities of chromosome No. 1 in human solid malignant tumours. Int J Cancer (1978) 0.83

The investigation of idiopathic infertility by in vitro fertilization. Fertil Steril (1980) 0.83

The symptomatology of the climacteric in relation to hormonal and cytological factors. Br J Obstet Gynaecol (1984) 0.83

Brachytherapy in the combined modality treatment of pediatric malignancies. Principles and preliminary experience with treatment of soft tissue sarcoma (recurrence) and Ewing's sarcoma. Klin Padiatr (1995) 0.83

Allelic changes at multiple regions of chromosome 5 are associated with progression of urinary bladder cancer. J Pathol (2000) 0.83

[Retinal damage by perfluorocarbon liquids - a question of specific gravity? Intraocular pressure peaks and shearing forces]. Klin Monbl Augenheilkd (2009) 0.82

Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma. Cancer Genet Cytogenet (2001) 0.82

Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction programme. Hum Reprod (1997) 0.82

Laparoscopic replacement of urinary tract segments using biodegradable materials in a large-animal model. J Endourol (1999) 0.80

Clonal chromosome aberrations in normal kidney tissue from patients with renal cell carcinoma. Cancer Genet Cytogenet (1989) 0.80

Cloning a calcium channel alpha2delta-3 subunit gene from a putative tumor suppressor gene region at chromosome 3p21.1 in conventional renal cell carcinoma. Gene (2001) 0.80

Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603. Cancer Res (1995) 0.80

Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum Reprod (2002) 0.80

Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors. Lab Invest (1997) 0.80

Early evaluation of postmenopausal hormonal steroid therapy by scanning electron microscopy of the uterine epithelium. Acta Anat (Basel) (1990) 0.79

p53 expression in correlation to clinical outcome in patients with renal cell carcinoma. Scand J Urol Nephrol (2001) 0.79

No evidence for loss of alleles at 11p in HBV negative hepatocellular carcinomas. Genes Chromosomes Cancer (1990) 0.79

Lack of interleukin 6 (IL-6) and transforming growth factor alpha (TGF-alpha) expression in chromophobe renal cell carcinomas. Br J Cancer (1998) 0.79

Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment. Kidney Int (2000) 0.79

[Interdisciplinary point of contact between rheumatology and pneumology]. Z Rheumatol (2008) 0.79

Magnetic resonance imaging of the shoulder in the primary care setting. Med Sci Sports Exerc (1998) 0.78

Preferential involvement of chromosome 1q in a primary breast carcinoma. Cancer Genet Cytogenet (1981) 0.78

Recommendations for the treatment of localized prostate cancer by permanent interstitial brachytherapy. Urol Int (2003) 0.77

Serial cytogenetic analysis in a patient with pseudodiploid bladder cancer. J Cancer Res Clin Oncol (1985) 0.77

Perinatal and obstetric outcomes of donor insemination using cryopreserved semen in Victoria, Australia. Hum Reprod (1999) 0.77

[Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with commentary of the Cologne Consensus Conference 2010]. Dtsch Med Wochenschr (2010) 0.77

Duplications of DNA sequences between loci D20S478 and D20S206 at 20q11.2 and between loci D20S902 and D20S480 at 20q13.2 mark new tumor genes in papillary renal cell carcinoma. Lab Invest (1999) 0.77

The incidence of non-specific infection in the semen in fertile and sub-fertile males. Int J Androl (1981) 0.77

Influence of growth hormone and insulin-like growth factor-I on kidney function and kidney growth. Pediatr Nephrol (1991) 0.77

Tertiary trisomy 14q--, due to paternal balanced translocation 46,XY,t(1;14)(q44;q22). Hum Genet (1979) 0.77

Deletion 3p: the only chromosome loss in a primary renal cell carcinoma. Cancer Genet Cytogenet (1987) 0.77

Equine leukocyte antigen system. II. Serological and mixed lymphocyte reactivity studies in families. Transplantation (1980) 0.77

A general-purpose system for long-term recording from a microelectrode array coupled to excitable cells. J Neurosci Methods (1993) 0.77

Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas. Oncogene (1997) 0.77

Observations on nuclear protrusions and the length of long arms of abnormal chromosomes in malignancy. Acta Cytol (1982) 0.77

[Clinical classification and initial diagnosis of pulmonary hypertension: recommendations of the Cologne Consensus Conference 2016]. Dtsch Med Wochenschr (2016) 0.77

Two chromosomally different cell populations in a partly cellular congenital mesoblastic nephroma. Arch Pathol Lab Med (1987) 0.76

Mapping the papillary renal cell carcinoma gene between loci D17S787 and D17S1799 on chromosome 17q21.32. Lab Invest (1999) 0.76

Short communication: deletion 7q, trisomy 6 and 11 in a case of Merkel-cell carcinoma. Cancer Genet Cytogenet (1988) 0.76

BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators. Br J Cancer (1999) 0.76